HELX Franklin Genomic Advancements ETF
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically, it seeks out firms that the investment manager believes are fundamentally dedicated to, or are poised to significantly benefit from, efforts to prolong and enhance the overall quality of life for both humans and animals. This is accomplished by integrating cutting-edge technological and scientific innovations, improvements, and breakthroughs in the field of genomics directly into their business models and operations.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| HELX | +2.4% | +6.1% | +18.3% | +23.8% | +16.6% | -3.0% |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: −$358K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| CRL CHARLES RIVER LABORATORIE | 1.76% | $3K | $20.3M |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | GH GUARDANT HEALTH INC | 8.72% |
| 2 | NTRA NATERA INC | 8.25% |
| 3 | ADPT ADAPTIVE BIOTECHNOLOGIES | 5.10% |
| 4 | KRYS KRYSTAL BIOTECH INC | 4.84% |
| 5 | LGND LIGAND PHARMACEUTICALS | 4.68% |
| 6 | BBIO BRIDGEBIO PHARMA INC | 3.42% |
| 7 | TWST TWIST BIOSCIENCE CORP | 3.22% |
| 8 | MEDP MEDPACE HOLDINGS INC | 2.89% |
| 9 | LLY ELI LILLY & CO | 2.84% |
| 10 | UTHR UNITED THERAPEUTICS CORP | 2.82% |
| 11 | VRTX VERTEX PHARMACEUTICALS IN | 2.79% |
| 12 | REGN REGENERON PHARMACEUTICALS | 2.55% |
| 13 | TVTX TRAVERE THERAPEUTICS INC | 2.43% |
| 14 | VYLR VYLOR INC | 2.19% |
| 15 | CDNA CAREDX INC | 2.12% |
| 16 | TEM TEMPUS AI INC-CL A | 2.07% |
| 17 | RGEN REPLIGEN CORP | 1.85% |
| 18 | GRAL GRAIL INC | 1.80% |
| 19 | CRL CHARLES RIVER LABORATORIE | 1.76% |
| 20 | NBIX NEUROCRINE BIOSCIENCES IN | 1.72% |
| 21 | ARGX.BR ARGENX SE | 1.61% |
| 22 | JAZZ JAZZ PHARMACEUTICALS PLC | 1.41% |
| 23 | KNSA KINIKSA PHARMACEUTICALS I | 1.20% |
| 24 | PRAX PRAXIS PRECISION MEDICINE | 1.16% |
| 25 | HNGE HINGE HEALTH INC-A | 1.13% |
| 26 | RPRX ROYALTY PHARMA PLC- CL A | 1.13% |
| 27 | IQV IQVIA HOLDINGS INC | 1.09% |
| 28 | PTCT PTC THERAPEUTICS INC | 1.06% |
| 29 | BNTX BIONTECH SE-ADR | 1.04% |
| 30 | 207940.KS SAMSUNG BIOLOGICS CO LTD | 1.00% |
| 31 | INSM INSMED INC | 1.00% |
| 32 | STOK STOKE THERAPEUTICS INC | 0.99% |
| 33 | TMO THERMO FISHER SCIENTIFIC | 0.98% |
| 34 | SRT3.DE SARTORIUS AG-VORZUG | 0.96% |
| 35 | TXG 10X GENOMICS INC-CLASS A | 0.92% |
| 36 | RVMD REVOLUTION MEDICINES INC | 0.85% |
| 37 | GMAB GENMAB A/S -SP ADR | 0.82% |
| 38 | TRAX FIRST TRACKS BIOTHERAPEUT | 0.76% |
| 39 | ETON ETON PHARMACEUTICALS INC | 0.76% |
| 40 | MRNA MODERNA INC | 0.75% |
| 41 | CDNS CADENCE DESIGN SYS INC | 0.72% |
| 42 | CRSP CRISPR THERAPEUTICS AG | 0.71% |
| 43 | A AGILENT TECHNOLOGIES INC | 0.70% |
| 44 | ANAB ANAPTYSBIO INC | 0.68% |
| 45 | GKOS GLAUKOS CORP | 0.66% |
| 46 | BEAM BEAM THERAPEUTICS INC | 0.61% |
| 47 | TGTX TG THERAPEUTICS INC | 0.59% |
| 48 | QIA.DE QIAGEN N.V. | 0.57% |
| 49 | AZN.L ASTRAZENECA PLC | 0.56% |
| 50 | VCYT VERACYTE INC | 0.56% |
| 51 | MANE VERADERMICS INC | 0.53% |
| 52 | ROIV ROIVANT SCIENCES LTD | 0.51% |
| 53 | AXSM AXSOME THERAPEUTICS INC | 0.45% |
| 54 | ARQT ARCUTIS BIOTHERAPEUTICS I | 0.41% |
| 55 | RYTM RHYTHM PHARMACEUTICALS IN | 0.38% |
| 56 | COGT COGENT BIOSCIENCES INC | 0.33% |
| 57 | CELC CELCUITY INC | 0.32% |
| 58 | ONC BEONE MEDICINES LTD-ADR | 0.31% |
| 59 | BIO BIO-RAD LABORATORIES-A | 0.30% |
| 60 | TARS TARSUS PHARMACEUTICALS IN | 0.29% |
| 61 | CTVA CORTEVA INC | 0.28% |
| 62 | MLYS MINERALYS THERAPEUTICS IN | 0.26% |
| 63 | LQDA LIQUIDIA CORP | 0.17% |
| 64 | NGNE NEUROGENE INC | 0.16% |
| 65 | 0126Z0.KS SAMSUNG EPISHOLDINGS CO L | 0.14% |
| 66 | WGS GENEDX HOLDINGS CORP | 0.10% |
| 67 | HELX CASH | 0.03% |
| 68 | 2200964 OMNIAB INC - 15.00 EARNOU | 0.00% |
| 69 | 2200963 OMNIAB INC - 12.5 EARNOUT | 0.00% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 30, 2025 | $0.1433 |
| Dec 30, 2021 | $0.0039 |
| Dec 13, 2021 | $0.1142 |
| Dec 14, 2020 | $0.0518 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in HELX in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error